References

Ataxia telangiectasia: A review

10.1186/s13023-016-0543-7 · 2016 · External reference

Chromosome instability syndromes

10.1038/s41572-019-0113-0 · 2019 · External reference

Ataxia telangiectasia: What the neurologist needs to know

10.1136/practneurol-2019-002253 · 2020 · External reference

Genotype, extrapyramidal features, and severity of variant ataxia-telangiectasia

10.1002/ana.25394 · 2019 · External reference

Ataxia-telangiectasia: Recommendations for multidisciplinary treatment

10.1111/dmcn.13424 · 2017 · External reference

A framework for individualized splice-switching oligonucleotide therapy

10.1038/s41586-023-06277-0 · 2023 · External reference

Modelling ATM mutant proteins from missense changes confirms retained kinase activity

10.1002/humu.21034 · 2009 · External reference

The state-of-the-art of N-of-1 therapies and the IRDiRC N-of-1 development roadmap

10.1038/s41573-024-01059-3 · 2025 · External reference

The burden of rare diseases

10.1002/ajmg.a.61124 · 2019 · External reference

The natural history of ataxia-telangiectasia (A-T): A systematic review

10.1371/journal.pone.0264177 · 2022 · External reference

Scale for the assessment and rating of ataxia: Development of a new clinical scale

10.1212/01.wnl.0000219042.60538.92 · 2006 · External reference

Lymphoid tumours and breast cancer in ataxia telangiectasia; substantial protective effect of residual ATM kinase activity against childhood tumours

10.1038/bjc.2011.266 · 2011 · External reference

Biomarker changes during 20 years preceding Alzheimer’s disease

10.1056/nejmoa2310168 · 2024 · External reference

10.1007/978-1-4419-0318-1

10.1007/978-1-4419-0318-1 · 2000 · External reference

Estimation of extended mixed models using latent classes and latent processes: The R package lcmm

10.18637/jss.v078.i02 · 2017 · External reference

An analysis of transformations

10.1111/j.2517-6161.1964.tb00553.x · 1964 · External reference

Unresolved reference

2008 · External reference

Serum alpha fetoprotein in Ataxia Telangiectasia: New lessons about an old biomarker

10.1016/j.ejpn.2026.02.006 · 2026 · External reference

Biomarkers in Ataxia-Telangiectasia: A systematic review

10.1007/s00415-024-12766-7 · 2025 · External reference

SARA captures disparate progression and responsiveness in spinocerebellar ataxias

10.1007/s00415-024-12475-1 · 2024 · External reference

Longitudinal analysis shows GAA1 length and baseline clinical status as robust predictors of progression in Friedreich ataxia

10.1007/s00415-026-13812-2 · 2026 · External reference

More than ataxia – movement disorders in ataxia-telangiectasia

10.1016/j.parkreldis.2017.12.009 · 2018 · External reference

Peripheral polyneuropathy in children and young adults with ataxia-telangiectasia

10.1111/ene.16028 · 2023 · External reference

Assessment of ataxia rating scales and cerebellar functional tests: Critique and recommendations

10.1002/mds.28313 · 2021 · External reference

Responsiveness of the scale for the assessment and rating of ataxia and natural history in 884 recessive and early onset ataxia patients

10.1002/ana.26712 · 2023 · External reference

Consensus recommendations for clinical outcome assessments and registry development in ataxias: Ataxia global initiative (AGI) working group expert guidance

10.1007/s12311-023-01547-z · 2024 · External reference

Exploring the clinical meaningfulness of the scale for the assessment and rating of ataxia: A comparison of patient and physician perspectives at the item level

10.1016/j.parkreldis.2021.08.014 · 2021 · External reference

Temporal dynamics of the scale for the assessment and rating of ataxia in spinocerebellar ataxias

10.1002/mds.29255 · 2023 · External reference